Interleukin-12 enhances murine survival against acute toxoplasmosis.
about
In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areasLong-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic InfectionsTreatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosisInduction of interferon-stimulated genes by IRF3 promotes replication of Toxoplasma gondiiCCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection.The CD8 T-cell road to immunotherapy of toxoplasmosis.A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in miceToxoplasma gondii triggers granulocyte-dependent cytokine-mediated lethal shock in D-galactosamine-sensitized mice.Acute and chronic phases of Toxoplasma gondii infection in mice modulate the host immune responses.Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice.Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivoLocalized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum.Lack of interleukin-12 in p40-deficient mice leads to poor CD8+ T-cell immunity against Encephalitozoon cuniculi infection.NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.Purified PTP1 protein induces antigen-specific protective immunity against Encephalitozoon cuniculi.Toxoplasma gondii: 25 years and 25 major advances for the fieldChemokine secretion of human cells in response to Toxoplasma gondii infectionModulation of innate immunity by Toxoplasma gondii virulence effectors.CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cellsToxoplasma gondii induces granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor secretion by human fibroblasts: implications for neutrophil apoptosis.The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartmentsContribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.Type II Toxoplasma gondii induction of CD40 on infected macrophages enhances interleukin-12 responsesInfection-induced regulation of natural killer cells by macrophages and collagen at the lymph node subcapsular sinus.Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cellsLack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite.CD8 T Cells and Toxoplasma gondii: A New ParadigmIL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondiiA critical role for SOCS3 in innate resistance to Toxoplasma gondii.Endogenous interleukin-12 is involved in resistance to Brucella abortus infection.Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection.Different roles for interleukin-4 during the course of Toxoplasma gondii infection.Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublinCR3-dependent resistance to acute Toxoplasma gondii infection in mice.Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondiiInterleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.Interleukin-12 regulation of host defenses against Coccidioides immitisInterleukin-12-induced adhesion molecule expression in murine liverVaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis.
P2860
Q24652833-18470FDB-C3C5-4BBA-97BF-723DC7CDE141Q28082315-68F844EB-027C-4F47-9CC5-AA14AD9E7CC9Q28379387-C18A5D4B-7DA5-4D87-8C84-E89CB6BFF9B8Q28545027-E9A5B467-2CB1-4341-813F-649DC051D26AQ33247466-CEF9C22B-2EBB-4C49-862D-C12D155E7E0EQ33732215-80CFC1BC-B597-476F-A03C-A9F6DBD61335Q33738007-DF51160C-00F6-4878-86DE-2D918E0F21ABQ33752033-9F34EE07-2D12-44CE-A654-6AA82A713398Q33755653-C384209C-08E3-4FD9-BB3C-BF5C83DECF2AQ33763350-242140E9-C5DD-4B2A-B741-76B4E53F6760Q33765923-07449847-AE7A-4552-BCF7-A6F8F44EED9FQ33792618-BDDE1AEA-527C-46A6-836B-5EEDCCA2F535Q33877209-123069F9-C012-44AE-9A79-7F4242E9A596Q33946628-F4D33C67-6134-49EF-A651-94A58AD43D9CQ33951467-77DDA203-C0AB-46EF-BFBA-F9E4F8F288C5Q33956789-5FC7692E-9687-449D-A07E-3D62EB432269Q34000765-55B898E6-C5E0-4DDF-BE44-94DD7DAA201BQ34033981-A8967923-716B-40BC-9658-C8593AEDA73AQ34116618-B0D68B5E-1E61-4D04-89AB-320A1187C18EQ34181009-C727FFC3-6E30-43F1-8291-7A5790A4B5B3Q34257220-C1EEA2DF-24E2-4E8E-AABA-669DB2329419Q34262167-3A6236A1-11DF-4D6B-A826-478A97D17382Q34298612-AFFB3923-A6AB-438E-855A-C4DFEA478194Q34354896-ECE1781C-BBF3-4F0E-9B9F-AAF5E5E0E8B4Q34577774-71938564-73A9-411A-8828-6FC6C5B5F342Q34597905-EC68FF8A-B662-4905-8112-A20AF8564420Q35038836-F1A2572D-CF5D-43D2-B152-3B345CA0E663Q35058854-6172F71B-F1FB-4C79-8A82-B5DA4EB465EBQ35222475-FE98CD0E-9EC9-4395-8D0C-70F7F8B0B411Q35401154-E1E4A656-3776-470F-BD52-2A59F562BBF9Q35444251-508B5EC0-7906-4D6F-94C0-68BBD0E2DCCDQ35474667-3D340464-F414-4992-9329-8F1FA59524E2Q35484698-5CE2EF1D-9FC4-4154-9849-B1A365C8FAC7Q35495536-DB445A09-6350-46E1-A277-68CFFF94E7E6Q35495758-72274332-2A3D-42E3-8D36-F40C9EB8B17FQ35501871-848A70D9-EBC0-4F05-814A-1897B9DAFFF2Q35516782-8473A065-642E-4228-8C7F-794C7D706CA8Q35763756-89C52671-3375-4826-8451-05F4C7130071Q35993075-3F89469B-ACAC-403D-A43B-95B89AFE15F6Q36364304-20B90635-23C4-4F99-B83D-EF7BB07455FC
P2860
Interleukin-12 enhances murine survival against acute toxoplasmosis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Interleukin-12 enhances murine survival against acute toxoplasmosis.
@ast
Interleukin-12 enhances murine survival against acute toxoplasmosis.
@en
type
label
Interleukin-12 enhances murine survival against acute toxoplasmosis.
@ast
Interleukin-12 enhances murine survival against acute toxoplasmosis.
@en
prefLabel
Interleukin-12 enhances murine survival against acute toxoplasmosis.
@ast
Interleukin-12 enhances murine survival against acute toxoplasmosis.
@en
P2093
P2860
P1476
Interleukin-12 enhances murine survival against acute toxoplasmosis.
@en
P2093
P2860
P304
P407
P577
1994-05-01T00:00:00Z